Literature DB >> 22416806

Age related prevalence of severe left ventricular hypertrophy in essential hypertension: echocardiographic findings from the ETODH study.

Cesare Cuspidi1, Stefano Meani, Carla Sala, Cristiana Valerio, Francesca Negri, Giuseppe Mancia.   

Abstract

AIM: We sought to investigate the prevalence and correlates of severe left ventricular hypertrophy (LVH) in relation to age in a large cohort of essential hypertensives referred to a single outpatient hypertension clinic.
METHODS: A total of 3752 (mean age 53±13 years, 53% men) untreated (29.5%) and treated hypertensive patients categorized in three age groups (I: 18-40 years; II: 41-64 years; III: ≥65 years) were considered for this analysis. All patients underwent extensive investigations searching for target organ damage. LVH, defined as LV mass ≥49/45 g/m(2.7) in men/women, respectively, was graded as mild, moderate and severe according to Lang's report.
RESULTS: LVH prevalence was 29.4% in group I, 48.2% in group II and 63.6% in group III. Overall, more than one fourth of patients with LVH had a severely increased LV mass index; the likelihood of having severe LVH was two- and four-fold higher in elderly hypertensives than in their middle-aged and young counterparts, respectively. Increasing age and LVH degree were both associated with a greater prevalence of concentric LV geometry as well as of extra-cardiac organ damage (i.e. carotid intima-media thickness).
CONCLUSIONS: LVH is a highly prevalent organ damage in essential hypertensives, particularly in the elderly, who exhibited a more severe increase of LV mass index, higher relative wall thickness and extra-cardiac organ damage compared with young and middle-aged sub-groups. Our findings suggest that the assessment of cardiovascular risk by grading LVH rather than simply defining the presence/absence of this cardiac phenotype could improve therapeutic strategies in the hypertensive population, particularly in the elderly.

Entities:  

Mesh:

Year:  2012        PMID: 22416806     DOI: 10.3109/08037051.2012.668662

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  8 in total

1.  Relationship between electrocardiographic left ventricular hypertrophy criteria and vascular structure and function parameters in hypertensive patients.

Authors:  M A Gómez-Marcos; J I Recio-Rodríguez; M C Patino-Alonso; C Agudo-Conde; E Rodríguez-Sánchez; L Gómez-Sánchez; M Gómez-Sánchez; L García-Ortiz
Journal:  J Hum Hypertens       Date:  2013-09-19       Impact factor: 3.012

2.  Independent influence of overweight and obesity on the regression of left ventricular hypertrophy in hypertensive patients: a meta-analysis.

Authors:  Kun Zhang; Feifei Huang; Jie Chen; Qingqing Cai; Tong Wang; Rong Zou; Zhiyi Zuo; Jingfeng Wang; Hui Huang
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

3.  Validity of electrocardiographic criteria for increased left ventricular mass in young patients in the general population.

Authors:  Eduard Sklyar; Paul Ginelli; Aaron Barton; Richard Peralta; Jonathan N Bella
Journal:  World J Cardiol       Date:  2017-03-26

4.  Oblique views of chest radiography from a designed rotation angle recommendation increase the contrast ratio between obscured lesions and surrounding structures.

Authors:  Hui-Chen Lin; Chung-Yao Huang; Wei-Ming Huang; Zong-Yi Jhou; Chia-Hung Chen; Yu-Chan Chien; Chun-Chao Huang
Journal:  Thorac Cancer       Date:  2019-08-12       Impact factor: 3.500

5.  Allopurinol treatment adversely impacts left ventricular mass regression in patients with well-controlled hypertension.

Authors:  Christopher R Gingles; Ruth Symon; Stephen J Gandy; Allan D Struthers; Graeme Houston; Thomas M MacDonald; Chim C Lang; Peter T Donnan; Jacob George
Journal:  J Hypertens       Date:  2019-12       Impact factor: 4.844

6.  Circulatory efficiency in patients with severe aortic valve stenosis before and after aortic valve replacement.

Authors:  S Nordmeyer; C B Lee; L Goubergrits; C Knosalla; F Berger; V Falk; N Ghorbani; H Hireche-Chikaoui; M Zhu; S Kelle; T Kuehne; M Kelm
Journal:  J Cardiovasc Magn Reson       Date:  2021-03-01       Impact factor: 5.364

7.  Clinical Data, Chest Radiograph and Electrocardiography in the Screening for Left Ventricular Hypertrophy: The CAR2E2 Score.

Authors:  Patrycja S Matusik; Amira Bryll; Agnieszka Pac; Tadeusz J Popiela; Paweł T Matusik
Journal:  J Clin Med       Date:  2022-06-22       Impact factor: 4.964

8.  Albuminuria is associated with left ventricular hypertrophy in patients with early diabetic kidney disease.

Authors:  Nan Wu; Weiwei Zhao; Kuanping Ye; Yintao Li; Min He; Bin Lu; Renming Hu
Journal:  Int J Endocrinol       Date:  2014-08-20       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.